Search results for Lly

Eli Lilly and Company 2026 Q1 - Results - Earnings Call Presentation

Here’s What the Street is Saying About Eli Lilly and Company (LLY)

Barclays Sees Reinforced Long-Term Growth Narrative for Eli Lilly and Company (LLY)

Eli Lilly: We Haven't Reached Its Peak Yet (Rating Upgrade)

Eli Lilly Just Got a Huge Vote of Confidence From Morgan Stanley -- and It's All About Mounjaro

The efficacy of Eli Lilly's new, still-in-development GLP-1 drug is gaining attention, but don't forget its older GLP-1 drugs just yet.

Eli Lilly to Acquire Kelonia Therapeutics

On April 20, 2026, Eli Lilly & Company (“Lilly”) and Kelonia Therapeutics, Inc. (“Kelonia”) announced an agreement for Lilly to acquire Kelonia in an all-cash transaction expec...

This Drug Stock Has Crushed the S&P 500 Over the Last Decade

Eli Lilly is leading the GLP-1 charge, but investors have already priced much of the good news into the stock.

Eli Lilly (LLY) – Among the 10 Safe Stocks to Buy for the Long Term in 2026

Great News for Eli Lilly Stock Investors!

The weight loss segment is poised to generate lucrative profits for Eli Lilly.

Is Eli Lilly Stock an Undervalued Stock to Buy?

Consumer demand for Eli Lilly's weight-loss treatments continues to rise.

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics]]>

Should You Add a Healthcare Stock to Your Portfolio This Month? And Should It Be Eli Lilly (LLY)?

Eli Lilly is a giant in the weight-loss drug realm, and it's aiming to grow more.

CSL Limited (CSLLY) Shareholder/Analyst Call - Slideshow

Forget Weight Loss Drugs: Here's An Even Better Reason to Invest in Eli Lilly

Eli Lilly has more to offer than some investors realize.

<![CDATA[Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics ]]>

Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout

Worth up to $7 billion, Lilly’s second recent acquisition of a company in the space is centered around a cell therapy that’s currently in early-stage testing for multiple myeloma.

May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion

May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion admin Tue, 05/26/2026 - 11:55 Lilly keeps pushing forward with deals and pipeline mome...

Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect

Better Long-Term Buy: Eli Lilly or Viking Therapeutics?

One is a behemoth, the other is a minnow, but both have promising opportunities in the GLP-1 space.

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio]]>

Amylyx (AMLX) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATEThursday, May 7, 2026 at 8 a.m. ETCALL PARTICIPANTSCo-Chief Executive Officer — Justin KleeCo-Chief Executive Officer — Joshua CohenChief Commer...

<![CDATA[Eli Lilly Enters Three Separate Acquisitions Totaling $3.83 Billion ]]>

Liquidia (LQDA) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DateMonday, May 11, 2026 at 8:30 a.m. ETCall participantsChief Executive Officer — Roger JeffsChief Financial Officer — Michael KasetaChief Commerci...

Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?

The weight loss drug market is on track to reach almost $100 billion.